Innovative Services and Award-Winning Programs
The Pulmonary Embolism Response Team (PERT) Consortium
A common cause of pulmonary hypertension is clots (emboli) in the pulmonary arteries. NewYork-Presbyterian is proud to be part of the Pulmonary Embolism Response Team (PERT) Consortium, a national initiative to advance the care of patients with pulmonary embolism by performing research, developing advanced treatment protocols, and educating clinicians and community members. We are following acute pulmonary embolism protocols including clot lysis, acute surgical embolectomy where appropriate with extracorporeal membrane oxygenation (ECMO) support as needed, and a team to provide close follow-up.
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy Programs
Both NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Weill Cornell Medicine offer a multidisciplinary program for chronic thromboembolic pulmonary hypertension (CTEPH), the end result of persistent obstruction of the pulmonary arteries by acute or recurrent pulmonary clots (emboli). The CTEPH program offers patients:
- Surgical approaches: An innovative procedure known as pulmonary thromboendarterectomy (PTE) clears the pulmonary arteries to address chronic CTEPH. We are one of the few U.S. centers and one of the largest in the country performing PTE, which has been shown to be the best treatment to extend a patient’s survival. We have performed over 220 pulmonary thromboendarterectomy surgeries, with excellent outcomes.
- Lung transplantation and supportive therapy with Extracorporeal Membrane Oxygenation (ECMO), a tool to take care of patients with heart failure and pulmonary hypertension.
- Interventional approaches: We are one of the few U.S. centers performing balloon pulmonary angioplasty (BPA) for CTEPH. BPA is a lesser invasive alternative for patients who either too high risk for pulmonary artery thromboendarterectomy or have had a recurrence of symptoms after surgery. We have performed over 40 procedures at NewYork-Presbyterian since the start of the program in 2016.
National Award-Winning ECMO Program
NewYork Presbyterian’s pulmonary hypertension programs provide the best care and the best outcomes to patients who suffer from both heart failure and pulmonary hypertension. The Adult Extracorporeal Membrane Oxygenation (ECMO) Program at NewYork-Presbyterian/ Columbia University Irving Medical Center is one of the largest, most experienced, and most innovative ECMO programs in the world, and it is one of only five adult ECMO centers in the world designated a Platinum Level Award for Excellence in Life Support from the Extracorporeal Life Support Organization (ELSO). The prestigious Platinum Level award is the highest distinction given by ELSO, and only achieved by a select number of institutions worldwide. Platinum Level recognizes programs that display exceptional care in the delivery of ECMO support in patients with severe cardiac or pulmonary failure.